What companies are ACRV's competitors?

Acrivon Therapeutics, Inc. Common Stock (ACRV)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does ACRV compare to its peers?

The peer comparison table on this page shows Acrivon Therapeutics, Inc. Common Stock (ACRV) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does ACRV operate in?

Acrivon Therapeutics, Inc. Common Stock (ACRV) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

ACRV

Acrivon Therapeutics, Inc. Common Stock

NASDAQ·Biotechnology · Healthcare

$1.76$0.07−3.56%

Pre-market·$1.83+3.97%

Market cap$75.42M·Market closed·Oct 22 4:00 PM EDT

Frequently Asked Questions About ACRV

What companies are ACRV's competitors?: Acrivon Therapeutics, Inc. Common Stock (ACRV)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does ACRV compare to its peers?: The peer comparison table on this page shows Acrivon Therapeutics, Inc. Common Stock (ACRV) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does ACRV operate in?: Acrivon Therapeutics, Inc. Common Stock (ACRV) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

ACRV

Acrivon Therapeutics, Inc. Common Stock

NASDAQ·Biotechnology · Healthcare

$1.76$0.07−3.56%

Pre-market·$1.83+3.97%

Market cap$75.42M·Market closed·Oct 22 4:00 PM EDT

Peers

Sort:


RLMDRLMDRelmada Therapeutics, Inc.	Relmada Therapeutics, Inc.	$3.29	$350.9M
RPTXRPTXRepare Therapeutics Inc.	Repare Therapeutics Inc.	$2.65	$114.2M
UNCYUNCYUnicycive Therapeutics, Inc.	Unicycive Therapeutics, Inc.	$3.94	$107.9M
VXRTVXRTVaxart, Inc.	Vaxart, Inc.	$0.44	$107.1M
CBUSCBUSCibus, Inc.	Cibus, Inc.	$1.40	$107.0M
IMUXIMUXImmunic, Inc.	Immunic, Inc.	$7.22	$98.5M
PMVPPMVPPMV Pharmaceuticals, Inc.	PMV Pharmaceuticals, Inc.	$1.31	$69.6M
BMEABMEABiomea Fusion, Inc.	Biomea Fusion, Inc.	$0.69	$49.9M
ATYRATYRaTyr Pharma, Inc.	aTyr Pharma, Inc.	$0.17	$16.7M
TCRXTCRXTScan Therapeutics, Inc.	TScan Therapeutics, Inc.	$0.22	$13.7M

Frequently Asked Questions About ACRV

What companies are ACRV's competitors?: Acrivon Therapeutics, Inc. Common Stock (ACRV)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does ACRV compare to its peers?: The peer comparison table on this page shows Acrivon Therapeutics, Inc. Common Stock (ACRV) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does ACRV operate in?: Acrivon Therapeutics, Inc. Common Stock (ACRV) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.